Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | SSTR5 | P35346 | 6/20 | 0.48 |
| ▸ | SSTR3 | P32745 | 5/20 | 0.48 |
| ▸ | SSTR2 | P30874 | 3/20 | 0.48 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.48 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.48 |
| ▸ | MCHR1 | Q99705 | 7/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8831093 | 0.91 | POLB (0.60) | POLBLMNAKMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL10526777 | 0.88 | POLB (0.52) | POLBLMNAKMT2ASSTR5SSTR3 | |
| SCHEMBL6810335 | 0.87 | POLB (0.52) | POLBLMNAKMT2ASSTR5SSTR3 | |
| SCHEMBL5840827 | 0.86 | SSTR5 (0.52) | POLBSSTR5SSTR3SSTR2SSTR1 | |
| SCHEMBL22053387 | 0.86 | SSTR5 (0.52) | POLBSSTR5SSTR3SSTR2SSTR1 | |
| SCHEMBL5841004 | 0.86 | SSTR5 (0.52) | POLBSSTR5SSTR3SSTR2SSTR1 | |
| SCHEMBL5841003 | 0.86 | SSTR5 (0.52) | POLBSSTR5SSTR3SSTR2SSTR1 | |
| SCHEMBL5840823 | 0.86 | SSTR5 (0.52) | POLBSSTR5SSTR3SSTR2SSTR1 | |
| SCHEMBL5840925 | 0.86 | SSTR5 (0.52) | POLBSSTR5SSTR3SSTR2SSTR1 | |
| SCHEMBL16632757 | 0.86 | SSTR5 (0.52) | POLBSSTR5SSTR3SSTR2SSTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5646123-A | Time dependent administration of oligosaccharide glycosides related to blood group determinants having a type I or type II core structure in reducing inflammation in a sensitized mammal arising form exposure to an antigen | ALBERTA RESEARCH COUNCIL (CA) | 1997-07-08 | — | — | US | disclosed |
| US-5580858-A | Immunosuppressive and tolerogenic modified Lewisx compounds | ALBERTA RESEARCH COUNCIL (CA) | 1996-12-03 | — | — | US | disclosed |
| WO-1993024505-A1 | REDUCING INFLAMMATION BY TIME DEPENDENT ADMINISTRATION OF OLIGOSACCHARIDES GLYCOSIDES RELATED TO BLOOD GROUP DETERMINANTS | ALBERTA RESEARCH COUNCIL (CA) | 1993-12-09 | — | — | WO | disclosed |